PMGC Unit to Present Breakthrough Muscle Preservation Asset

 

Northstrive Biosciences Inc. was invited to present EL-22, a novel myostatin asset aimed at preserving muscle while on weight loss treatments, at the UCLA Obesity Symposium called Anti-Obesity Treatments: Challenges and Emerging Solutions, organized by UCLA Metabolism Theme.

Northstrive Biosciences’ management is scheduled to present on Friday, February 7th at 11:30 am PT.

https://www.globenewswire.com/news-release/2025/01/24/3014867/0/en/Northstrive-Biosciences-Inc-a-Subsidiary-of-PMGC-Holdings-Inc-to-Present-Breakthrough-Muscle-Preservation-Asset-at-Exclusive-UCLA-Obesity-Symposium.html